Difficult-to-treat psoriatic arthritis (PsA) refers to cases where patients continue to experience active disease despite the use of conventional and advanced therapies. These patients often present with persistent joint inflammation, enthesitis, axial involvement, or significant skin manifestations that are refractory to treatment. The condition is further complicated by comorbidities such as obesity, fibromyalgia, and depression, which can mask or amplify symptoms. Managing difficult-to-treat PsA requires a nuanced, individualized approach that considers both disease activity and patient-reported outcomes.
To keep you updated on difficult-to-treat psoriatic arthritis, we, in collaboration with the Women Health in Rheumatology Association and Bharati Vidyapeeth, present an informative session by renowned rheumatologist Dr. Ashish Jacob Mathew on 2 nd August 2025 at 2:00 PM IST . WHIRA…
